Valuation: OneSource Specialty Pharma Limited

Market Cap 186B 1.95B 1.69B 1.57B 1.45B 2.73B 2.77B 18.55B 7.28B 92.45B 7.31B 7.14B 310B P/E 2026
-229x
P/E 2027 * 40x
Enterprise Value 196B 2.06B 1.79B 1.67B 1.53B 2.89B 2.93B 19.63B 7.71B 97.83B 7.73B 7.56B 328B EV / Sales 2026
12.7x
EV / Sales 2027 * 8.92x
Free-Float
61.97%
Yield 2026 *
-
Yield 2027 * -
1 day-4.06%
1 week-2.07%
1 month-1.71%
3 months-6.81%
6 months+35.60%
Current year-10.54%
1 week 1,601.5
Extreme 1601.5
1,755.2
1 month 1,506.1
Extreme 1506.1
1,755.2
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
1,946.1
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 01/03/2024
Director of Finance/CFO - 04/07/2024
Compliance Officer - 14/03/2023
Director TitleAgeSince
Director/Board Member 65 07/04/2021
Director/Board Member 54 01/03/2024
Director/Board Member 66 27/02/2025
Change 5-day change 1-year change 3-year change Capi.($)
-4.06%-2.07%-17.95% - 1.95B
-1.40%+2.59%-1.71%+11.28% 48.53B
-2.41%-0.90%+403.17%+614.40% 39.87B
-1.16%+12.96%+26.45%+5.03% 38.68B
-1.88%-3.03%+4.94%+47.52% 35.13B
-1.74%+5.12%+9.58%+46.02% 29.79B
-2.85%-3.92% - - 16.08B
-0.21%-4.04%+35.09%+127.95% 16.11B
-0.64%+2.65%+1.25%+8.92% 13.61B
-1.19%-1.32%-3.32%-34.94% 12.62B
Average -1.75%+0.74%+50.83%+103.27% 25.24B
Weighted average by Cap. -1.62%+2.00%+76.09%+128.10%

Financials

2026 2027 *
Net sales 13.41B 141M 122M 114M 104M 197M 200M 1.34B 526M 6.68B 528M 516M 22.39B 21.8B 228M 199M 185M 170M 320M 325M 2.18B 855M 10.85B 858M 839M 36.39B
Net income -1.19B -12.47M -10.84M -10.09M -9.26M -17.49M -17.76M -119M -46.68M -593M -46.83M -45.8M -1.99B 4.46B 46.71M 40.61M 37.79M 34.7M 65.53M 66.54M 446M 175M 2.22B 175M 172M 7.44B
Net Debt 10.81B 113M 98.41M 91.6M 84.1M 159M 161M 1.08B 424M 5.38B 425M 416M 18.04B 8.86B 92.77M 80.65M 75.06M 68.92M 130M 132M 885M 347M 4.41B 348M 341M 14.78B
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.
Employees
1,412
Date Price Change Volume
31/07/26 ₹1,619.70 -4.06% 430,272
30/07/26 ₹1,688.30 -3.51% 163,785
29/07/26 ₹1,749.70 +1.06% 204,534
28/07/26 ₹1,731.30 +2.51% 384,200
27/07/26 ₹1,688.90 +2.12% 717,187
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,619.70INR
Average target price
2,056.00INR
Spread / Average Target
+26.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock